Search Results
-
How COVID-19 virus infects nasal cells
A discovery by Stanford Medicine researchers and colleagues may pave the way for a “morning after” or prophylactic nasal spray to prevent infection.
-
Blood test identifies infections
A diagnostic test developed by Stanford Medicine scientists can separate bacterial and viral infections with 90% accuracy, the first to meet standards set by the World Health Organization.
-
Mice with diabetes regain blood sugar control
A technique developed at Stanford Medicine allows mice with diabetes to accept unmatched islet cells and durably restores blood sugar control without immunosuppression or graft-versus-host disease.
-
What to know about polio
The first polio case in the U.S. since 2013 emerged in July, and cases have increased abroad. Yvonne Maldonado answers questions about the virus and its impacts.
-
Viral genome packing key in replication
Disrupting a virus’s genome packaging can halt replication and jumpstart a natural immune response against subsequent exposures, a Stanford Medicine study finds.
-
Magazine explores molecules within us
The new issue of Stanford Medicine magazine features articles about the molecules that make us who we are and how understanding them can lead to medical discoveries and innovations.
-
Immunosuppression-free kidney transplant
Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.
-
Microbiologist Hugh McDevitt dies at 91
The Stanford immunologist’s research on how our immune cells recognize pathogens — and what happens when this process goes wrong — paved the way to modern immunology.
-
Pediatric bowel disease center launches
A $70 million donation will enable researchers to offer more treatments to Stanford Children's Health patients suffering from inflammatory bowel disease or celiac disease.
-
‘Military police’ cells stem autoimmunity
A new study has identified a way that the immune system shoots down its own cells when their anti-viral activity threatens to become friendly fire. The finding could pave the way to new treatments for autoimmune diseases.